Trial intelligence / Profile preview

Aggressive Empiric Antibiotic Therapy for Pneumonia Requiring Mechanical Ventilation

NCT01570192Phase 2Terminated

Sponsor
University of Florida
Start
Sep 2010
Primary completion
Apr 2015
Modality
Nanoparticles, Implantable Devices, Transdermal Patches
Countries
4
01

Overview

A Phase 2 trial of tobramycin, gentamicin, amikacin in bacterial pneumonia, sponsored by University of Florida. Started Sep 2010; status: terminated.

02

Drugs

tobramycingentamicinamikacin
03

Conditions

bacterial pneumonia

Beyond the preview

Go deeper on NCT01570192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01570192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call